Enovis

ENOV - EnovisDividends

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

See below the complete and updated table with all dividends paid and declared history, etc

Excluding DateValue (U$)Frequency
8/5/2016
0,063
-

The latest dividend from ENOV was $0.063 per share (ex-dividend 8/5/2016). The dividend yield over the last 12 months is 0%.